ePrivacy and GPDR Cookie Consent by Cookie Consent

OncoDNA completes its portfolio with advanced genomic services and NGS data analysis tools

Yuliya Bahdanovich

June 14, 2021

NEWS

FOLLOWING THE ACQUISITION OF INTEGRAGEN, ONCODNA HAS CREATED A UNIQUE, INTEGRATED PORTFOLIO OF SMART AND PERSONALIZED SOLUTIONS TO HELP CLINICIANS, ACADEMIC RESEARCHERS AND BIOPHARMA COMPANIES ACROSS THE WORLD TO OUTSMART THE MOLECULAR COMPLEXITY OF CANCER AND GENETIC DISEASES. 

Since the successful takeover of IntegraGen in November 2020, OncoDNA has been working hand in hand with its new partner towards the consolidation of their respective teams and services. The acquisition brought together two companies of complementary expertise. While OncoDNA biomarker tests are recognized for guiding and monitoring the treatment of advanced cancer patients, IntegraGen is a leading player in DNA sequencing services with specialized expertise in exome and complete genome analyses. The company runs one of the largest NGS labs in France and operates for research institutes of excellence. Not to mention that it has also developed a variety of software for genomic data interpretation that are already commercialized in Europe and the USA.

With IntegraGen on board, OncoDNA is leveraging the power of next generation sequencing to bring precision medicine to a new level. Comprehensive genomic analysis has become increasingly important for diagnostic and research of complex genetic diseases such as cancer. By combining their forces, OncoDNA group has the potential to become the European leader in this emerging field. It took on the challenge of offering the best of genomic analyses and software with the objective of facilitating the translation of therapeutic innovation to the clinics and having a greater impact on patient care.

From now on, OncoDNA group will offer a unique, highly integrated portfolio that addresses the needs of the whole value chain – from translational research and drug development to patient treatment and monitoring. Through a comprehensive range of genomic services, biomarker tests, data interpretation and clinical decision support tools, it will provide academic researchers, biopharma companies and clinicians the molecular insights they need for their research projects, clinical trials and clinical decision-making. 

Comprehensive Biomarker Test

 

Unique combination of DNA, RNA and protein analyses on a tumor tissue to support clinical decisions at diagnosis or disease progression.

Targeted Liquid Biopsy

 

Fast and minimally invasive analysis of cancer-specific genomic panels for lung, colorectal and breast cancer patients.

Personalized Liquid Biopsy

 

Analysis of ctDNA to monitor tumor progression in real time and detect lack of response or resistance to treatment as soon as it appears.

DNA Sequencing

 

Exome, whole genome and custom gene panel sequencing services for cancer and rare diseases.

Transcriptomics

 

RNA sequencing services to precisely measure transcriptome expression in tissue samples or liquid biopsies.

Epigenomics

 

Cost-effective and high-throughput services to analyze genome-wide methylation profiles.

SNP Genotyping

 

Cost-effective and flexible services to interrogate 10’s to millions SNP markers in a timely manner.

Clinical Decision Support for clinical use

 

Secured interface reporting the clinical recommendations resulting from our biomarker tests and connecting you with other cancer professionals.

NGS data interpretation for clinical use

 

Interactive platform that transforms the raw NGS data coming from your lab into clear clinical guidance for late stage cancer patients.

NGS data interpretation for research use

 

User-friendly interface to quickly and intuitively analyze DNA and RNA sequencing data from tumor samples, including FFPE and cf-DNA.

RNA-Seq Data Exploration for research use

 

Intuitive app for the dynamic exploration of RNA sequencing data, enabling navigation intro expression profile, immediate analysis, annotations and data exportation.

Genomic Consulting

 

Tailored consulting and support for an advanced biostatistical and bioinformatic analysis of genomic data ranging from the initial design of genomic research projects to the detailed evaluation of research results.

NGS Data Exploration for research use

 

Cloud-based app for a tailored and in-depth analysis of the whole genome, whole exome and gene panel sequencing data when exploring genetic diseases.